22nd Century Group Inc. (XXII) Starts Presentation at 9th Annual LD Micro Invitational
22nd Century Group (NYSE: XXII) is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company’s primary mission in tobacco is to reduce the harm caused by smoking. The company’s primary mission in hemp/cannabis is to develop proprietary hemp strains for important new medicines and agricultural crops. For more information, visit the company's website at www.xxiicentury.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and…